HeyJaredVeracyte
Veracyte is a global cancer diagnostics company that empowers physicians to make the best possible decisions for patients at pivotal moments. We work closely with physicians and scientists to identify unmet needs that stand in the way of better care.
- Indexed videos, last 90 days
- 14
- Latest publication
- Jul 6, 2026
- Audience
- ~625 subscribers
- Earliest in this view
- Jul 6, 2026
Latest videos
Decipher Prostate | RTOG 9601 Trial Post RP (opens the original)
Read excerpt
Backed by extensive clinical evidence, the Decipher® Prostate Genomic Classifier helps clinicians and their patients with prostate cancer make informed decisions for personalized treatment. Join Dr. Daniel Spratt, when he was a Radiation Oncologist at the University of Michigan, as he discusses the analysis of Decipher Prostate in the RTOG 9601 randomized Phase III trial, where patients with rising PSA post-radical prostatectomy (RP) received salvage radiotherapy with or without hormone therapy.
Decipher Prostate | Genomics in Intermediate Risk Prostate Cancer (opens the original)
Read excerpt
Backed by extensive clinical evidence, the Decipher® Prostate Genomic Classifier helps clinicians and their patients with prostate cancer make informed decisions for personalized treatment. Join Dr. Ashley Ross, Ph.D., Urologist, Northwestern University, and Dr. Phuoc Tran, Ph.D., Radiation Oncologist, Johns Hopkins School of Medicine, as they discuss treatment decisions for intermediate risk disease. Addressing the challenges of intermediate risk prostate cancer, which presents heterogeneous ou
Decipher Prostate | Post-RP Radiation Therapy (opens the original)
Read excerpt
Join Dr. Edouard Trabulsi, FACS, Professor and Vice Chair Department of Urology, and Dr. Robert Den, Associate Professor of Radiation Oncology, Thomas Jefferson University, as they discuss how genomic testing, like the Decipher® Prostate test, can guide and inform multidisciplinary management of post-radical prostatectomy (RP) radiation therapy. Dr. Trabulsi and Dr. Den cover clinical data that informs decisions about early versus late radiation therapy for men with adverse pathology, along with
Decipher Prostate | A Urologist’s Personal Decipher Prostate Journey (opens the original)
Read excerpt
Urologist Dr. Arnold Bullock, from the Washington University School of Medicine, shares his very personal story of being diagnosed with prostate cancer and using the Decipher® Prostate test in his clinical practice for his patients. Watch his conversation with urologist and former colleague, Dr. Eric Kim, a key opinion leader from the University of Nevada, Reno School of Medicine. Backed by extensive clinical evidence, the Decipher Prostate Genomic Classifier helps clinicians and their patients
Decipher Prostate | Decipher Prostate GRID Report (opens the original)
Read excerpt
Decipher Prostate GRID (Genomic Resource for Intelligent Discovery) is a groundbreaking platform and database with more than 360K whole-transcriptome profiles from patients with urologic cancers. Available as a Research Use Only (RUO) tool to clinicians, Decipher Prostate GRID is the result of a dynamic collaboration between Veracyte and leading research partners dedicated to deepening our understanding of prostate and urologic cancers and uncovering new possibilities in personalized patient car
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
~625 subscribers
Measured Sep 19, 2026
Source's subscribers, not the number who saw an individual piece.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.